GGrantIndex
Sort

34,240 grants matching atherosclerosis

Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis

$393,750
Babak Razani · Washington University · R01 · FY2021 · HL

Central actions of angiotensin II in the control of fluid balance

$393,750
Daniel K Yee · University Of Pennsylvania · R01 · FY2010 · HL

Genetics of Vascular Remodeling

$393,750
University Of Rochester · R01 · FY2004 · HL

Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis

$393,748
Babak Razani · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL

Mechanisms of Glycosaminoglycan-Catalyzed Protease Inactivation by Serpins

$393,746
Ingrid M Verhamme · Vanderbilt University Medical Center · R01 · FY2018 · HL

Mechanisms of Glycosaminoglycan-Catalyzed Protease Inactivation by Serpins

$393,740
Ingrid M Verhamme · Vanderbilt University Medical Center · R01 · FY2019 · HL

INTEGRIN aMb2:STRUCTURE AND ATHEROTHROMBOTIC FUNCTIONS

$393,708
Edward F Plow · Cleveland Clinic Lerner Com-Cwru · P50 · FY2006 · HL

Noninvasive qualitative and quantitative assessment of vascular disease in vivo

$393,699
Elisa E Konofagou · Columbia Univ New York Morningside · R01 · FY2012 · HL

Integrin Signaling In Vascular Cells

$393,639
Susan S Smyth · University Of Kentucky · R01 · FY2008 · HL

NETs in the development of lupus and its cardiovascular complications

$393,580
Daniel T Eitzman · University Of Michigan At Ann Arbor · R01 · FY2014 · HL

Role of Innate Immune Mechanisms in Atherogenesis

$393,535
Joseph L Witztum · University Of California, San Diego · P01 · FY2011 · HL

PPARy, TLR Signaling and Atherosclerosis

$393,534
Christopher K Glass · University Of California, San Diego · P01 · FY2011 · HL

The Role of Vascular MR-Regulated Genes in Vascular Function and Disease

$393,525
Iris Z Jaffe · Tufts Medical Center · R01 · FY2012 · HL

Role of Pannexins in Vascular Smooth Muscle Cells

$393,523
Brant E Isakson · University Of Virginia · P01 · FY2016 · HL

Role of Pannexins in Vascular Smooth Muscle Cells

$393,523
Brant E Isakson · University Of Virginia · P01 · FY2014 · HL

Role of Pannexins in Vascular Smooth Muscle Cells

$393,523
Brant E Isakson · University Of Virginia · P01 · FY2018 · HL

Role of Pannexins in Vascular Smooth Muscle Cells

$393,523
Brant E Isakson · University Of Virginia · P01 · FY2017 · HL

Genetic insights into atherosclerosis and other cardiovascular diseases

$393,522
Paul M Hwang · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity

$393,500
Nazish Sayed · Stanford University · R01 · FY2024 · HL

Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity

$393,500
Nazish Sayed · Stanford University · R01 · FY2023 · HL

Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity

$393,500
Nazish Sayed · Stanford University · R01 · FY2022 · HL

Role of CHF1 in Occlusive Vascular Disease

$393,495
Michael T Chin · University Of Washington · R01 · FY2008 · HL

PKC Activation and Cardiovascular Disease in Diabetes

$393,495
George L King · Joslin Diabetes Center · R01 · FY2007 · DK

Role of CHF1 in Occlusive Vascular Disease

$393,495
Michael T Chin · University Of Washington · R01 · FY2007 · HL

Intravascular Fluorescence Molecular Imaging of Inflammation in Atherosclerosis

$393,458
Farouc Amin Jaffer · Massachusetts General Hospital · R01 · FY2010 · HL